ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646278 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646278; 2) Community: the network communities that were significantly associated with the response to NSC 646278; 3) Molecule: the relationships between components within communities and NSC 646278; 4) MDR: the compounds that were significantly associated with the NSC 646278.

NSC Compound Enrichment Correlation
NSC 677174 Null 0.0438391811600409 0.0004644647
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.0438391811600409 0.24813464
NSC 681645 Camptothecin Derivative 0.0438391811600409 0.61160975
NSC 682011 Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- 0.0438391811600409 0.16517741
NSC 683558 Camptothecin Derivative 0.0438391811600409 0.59422456
NSC 691243 Null 0.0438391811600409 0.53631409
NSC 696257 2,3-Dihydro-1,2-syn-2-[S-(L)-cysteinylsulfoxide-]-brefeldin A 0.0438391811600409 -0.071736061
NSC 697653 Null 0.0438391811600409 0.50381629
NSC 699940 Null 0.0438391811600409 0.20875612
NSC 704066 2,3-Dihydro-(3R)-[2-(diethylphosphono)ethylseleno]brefeldin A 0.0438391811600409 -0.20076944
Total:92  Current:82    [First] [Prev] [Next] [Last]